ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality improvement"

  • Abstract Number: 0256 • ACR Convergence 2021

    Consensus Approach to a Treat to Target Strategy in Juvenile Idiopathic Arthritis Care: Report from the 2020 Pediatric Rheumatology Care and Outcomes Improvement Network Consensus Conference

    Tala El Tal1, Meghan Ryan2, Brian Feldman3, Catherine Bingham4, Jon Burnham5, Michelle Batthish6, Danielle Bullock7, Kerry Ferraro8, Mileka Gilbert9, Beth Gottlieb10, Julia Harris11, Melissa Hazen12, Ronald Laxer13, Tzielan Lee14, Daniel Lovell15, Melissa Mannion16, Laura Noonan17, Edward Oberle18, Anne Paul19, Janalee Taylor20, Jennifer Weiss21, Cagri Yildirim-Toruner22 and Esi Morgan23, 1University of Toronto/Hospital for Sick Children, Toronto, ON, Canada, 2University of Minnesota, Vadnais Heights, MN, 3The Hospital for Sick Children, Toronto, ON, Canada, 4Penn State Children's Hospital, Allentown, PA, 5Children's Hospital of Philadelphia, Philadelphia, PA, 6McMaster University, Hamilton, ON, Canada, 7University of Minnesota, Minneapolis, MN, 8Pediatric Rheumatology Care and Outcomes Improvement Network, Cincinnati, OH, 9Medical University of South Carolina, Charleston, SC, 10Cohen Children's Medical Center, Lake Success, NY, 11Children's Mercy Kansas City, Overland Park, KS, 12Boston Children's Hospital, Boston, MA, 13SickKids, Toronto, ON, Canada, 14Stanford University School of Medicine, Palo Alto, CA, 15Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH, 16University of Alabama at Birmingham, Birmingham, AL, 17Levine Children's Hospital/Carolinas Healthcare System, Charlotte, NC, 18Nationwide Children's Hospital, Columbus, OH, 19Cincinnati Children's Hospital Medical Centre, Cincinnati, OH, 20Cincinnati Children's Hospital, Cincinnati, OH, 21Hackensack University Medical Center, Hackensack, NJ, 22Texas Children's Hospital/Baylor College of Medicine, Houston, TX, 23Seattle Children's Hospital, Seattle, WA

    Background/Purpose: Treat to target (T2T) is a strategy of adjusting treatment until a therapeutic target is reached. There is growing evidence supporting the use and…
  • Abstract Number: 0627 • ACR Convergence 2021

    Increasing Rates of Standardized Depression Screening in Adolescents and Young Adults with Childhood-Onset Systemic Lupus Erythematosus in a Pediatric Rheumatology Clinic

    Emily Datyner1, Manda Mitchell1, Brooke Fine1, Barron Patterson1, T. Brent Graham1 and Alaina Davis2, 1Vanderbilt University Medical Center, Nashville, TN, 2Vanderbilt Universty Medical Center, Nashville, TN

    Background/Purpose: Depression is common and adversely affects health outcomes in adolescents and young adults with childhood-onset systemic lupus erythematous (cSLE).1,2 The aim of our quality…
  • Abstract Number: 0657 • ACR Convergence 2021

    Assessing Patient Transition Outcomes from a Large Pediatric Rheumatology Center to Adult Healthcare

    Mary Robichaux1, Bernard Danna2, Monique Maher2, David McDonald1, Kristiana Nasto1, Alexander Alexander1, Ariel Coleman3, Danielle Guffey1 and Tiphanie Vogel1, 1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 3Texas Children's Hospital, Houston, TX

    Background/Purpose: Transitioning children with chronic diseases from pediatric to adult healthcare can be a challenging task, with high morbidity and mortality. In response, we have…
  • Abstract Number: 174 • 2020 Pediatric Rheumatology Symposium

    Improving Hospital Discharge Instructions for Pediatric Rheumatology Patients

    Laura Ballenger1, Vidya Sivaraman 2, Stephanie Lemle 3 and Kyla Driest 1, 1Division of Rheumatology, Nationwide Children's Hospital, Columbus, 2Division of Rheumatology, Nationwide Children's Hospital, Bexley, 3Quality Improvement Services, Nationwide Children's Hospital, Columbus

    Background/Purpose: Communication, including clear discharge instructions, is a crucial aspect of the hospital discharge process. Development of standardized discharge templates has been reported to improve…
  • Abstract Number: 190 • 2020 Pediatric Rheumatology Symposium

    Outcomes of an Evidence Based Guideline for the Treatment of Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome

    Kacie Hoyt1, Olha Halyabar 2, Joseph Han 3, Siobhan Case 4, Margaret Chang 5, Ezra Cohen 6, Fatma Dedeoglu 5, Mark Gorman 7, Jonathan Hausmann 8, Erin Janssen 2, Pui Lee 9, Jeffrey Lo 5, Mindy Lo 5, Esra Meidan 10, Peter Nigrovic 1, Jordan Roberts 5, Mary Beth Son 1, Robert Sundel 2, Barbara Degar 5, Melissa Hazen 7 and Lauren Henderson 11, 1Boston Children's Hospital, Boston, Massachusetts, 2Children's Hospital/Boston Medical Center, Boston, 3Mount Sinai School of Medicine, New York, 4Brigham and Women's Hospital, Boston, Massachusetts, 5Boston Children's Hospital, Boston, 6, 7Boston, 8Division of Immunology, Boston Children's Hospital; Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 9Boston Children's Hospital, Newton, 10Somerville, 11Boston Children's Hospital, Watertown, Massachusetts

    Background/Purpose: Rapid identification of hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) coupled with a multidisciplinary approach to management is essential to improve patient outcomes.…
  • Abstract Number: 192 • 2020 Pediatric Rheumatology Symposium

    Single Center Consensus of Prophylactic Treatment in Immunocompromised Children with Rheumatic Disease

    Stephen Wong1, Amy Gaultney 2 and Deborah McCurdy 3, 1University of California Los Angeles, Los Angeles, California, 2UCLA, Los Angeles, California, 3UCLA Medical Center, Los Angeles, California

    Background/Purpose: Many children with rheumatic diseases require immunosuppressive treatments, however these medications put them at risk for contracting opportunistic infections leading to severe morbidity and…
  • Abstract Number: 006 • 2020 Pediatric Rheumatology Symposium

    Increasing Rates of Standardized Depression Screening in Youth with Systemic Lupus Erythematosus in a Pediatric Rheumatology Clinic

    Victoria Newsome 1, Jodi Dingle 2, Manda Mitchell 3, Thomas Brent Graham 4 and Alaina Davis5, 1Nashville, 2Vanderbilt University Medical Center, Nashville, Tennessee, 3Nashville, Tennessee, 4Vanderbilt University Medical Center, Nashville, 5Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, Tennessee

    Background/Purpose: Depression is common among youth with SLE.  Early identification and treatment of depression has the potential to improve health outcomes for youth with SLE.…
  • Abstract Number: 037 • 2020 Pediatric Rheumatology Symposium

    Improving Pneumococcal Vaccination Rates in Immunosuppressed Rheumatology Patients

    Julia Harris1, Michael Holland 2, Emily Fox 2, Amy Ivy 2, Maria Ibarra 2, Cara Hoffart 2, Jordan Jones 2, Leslie Favier 3 and Ashley Cooper 2, 1Children's Mercy Kansas City, Overland Park, 2Children's Mercy Kansas City, Kansas City, 3Children's Mercy Kansas City, Leawood

    Background/Purpose: The Centers for Disease Control and Prevention recommends pneumococcal vaccination of high-risk patients, including patients on iatrogenic immunosuppression. Many patients seen in the rheumatology…
  • Abstract Number: 039 • 2020 Pediatric Rheumatology Symposium

    Assessing Patient Self-Reported Transition Readiness in a Large Pediatric Rheumatology Center

    Priyanka Moolchandani 1, Alexander Alexander 1, Cristina Saez 1, JaLeen Rogers 2, Ariel Coleman 2, Anne Dykes 2, Miriah Gillispie-Taylor 3 and Tiphanie Vogel1, 1Baylor College of Medicine, Houston, 2Texas Children's Hospital, Houston, 3Levine Children's Hospital, Charlotte

    Background/Purpose: Patients with childhood-onset rheumatologic diseases live well into adulthood and need effective transition from pediatric to adult medical providers. Fortunately, predictors of successful transition…
  • Abstract Number: 086 • 2020 Pediatric Rheumatology Symposium

    Advanced Multidisciplinary Care: A New Approach to Childhood Arthritis

    Julia Brooks1, Dorothy Adams 2, Robin Hellweg 1, Maggie Mercer 1, Joni Shair 2, Dwaraka Veeramreddy 3, Aynsley Wennberg 1 and Heinrike Schmeling 4, 1Alberta Children's Hospital, Calgary, Alberta, Canada, 2Alberta Children's Hospital, Calgary, Canada, 3Alberta Children's Hospital/University of Calgary, Calgary, Canada, 4Alberta Children's Hospital/University of Calgary, Calgary, Alberta, Canada

    Background/Purpose: Many patients are overwhelmed with the diagnosis of chronic childhood arthritis and require long-term treatments. Our objective was to develop a new, child and…
  • Abstract Number: 173 • 2020 Pediatric Rheumatology Symposium

    Impact of a Nutrition-Focused Quality Improvement Intervention on Hospital Readmission Rates in Henoch-Schönlein Purpura with Gastrointestinal Involvement

    Maria Pereira1, Miriah Gillispie-Taylor 2, Pooja Patel 3, Michael Nelson 4, Ugo Awa 4, Monica Bray 5, Amanda Brown 4, Andrea Ramirez 6, MaiLan Nguyen 4, Saimun Singla 4, Tiphanie Vogel 4, Eyal Muscal 5, Marietta De Guzman 6, Elisabeth Hastings 7, Ashleigh Russell 7 and Kristina Lakenmacher 7, 1Assistant Professor, Section of Rheumatology, Division of Pediatrics, Baylor College of Medicine, Houston, Texas, 2Levine Children's Hospital, Charlotte, 3Baylor College of Medicine, Houston, Texas, 4Baylor College of Medicine, Houston, 5Section of Rheumatology, Department of Pediatrics, Baylor College of Medicine, Houston, 6Section of Rheumatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, 7Texas Children's Hospital, Houston

    Background/Purpose: Henoch-Schönlein Purpura (HScP) is the most common form of vasculitis in children, with gastrointestinal (GI) complaints occurring in more than a third of patients…
  • Abstract Number: 1126 • 2019 ACR/ARP Annual Meeting

    A Medical Assistant Driven Quality Improvement Intervention Increases Rates of DEXA Screening Among RA Patients

    Sarah French1, Joshua Ng 1, Darlene Young 2, Michael Evans 3, Tobias Schmelzinger 1, Gabriela Schmajuk 4, Jinoos Yazdany 5 and Andrew Gross 1, 1UCSF, San Francisco, CA, 2UCSF, San Francisco, 3University of California San Francisco, San Francisco, 4UCSF, SFVAMC Division of Rheumatology, San Francisco, CA, 5UCSF Division of Rheumatology, San Francisco, CA

    Background/Purpose: Rheumatoid arthritis (RA) patients are at increased risk for developing osteoporosis as compared to the general population, even after controlling for glucocorticoid use[1]. Identification…
  • Abstract Number: 1136 • 2019 ACR/ARP Annual Meeting

    Improving Access in an Academic Rheumatology Department by Reducing the No Show Rate

    Richard Zamore1, 1Hospital of the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: No shows are a widespread problem across medical practices, and lead to negative consequences for patients and providers (Mendel 2017). The rheumatology division at…
  • Abstract Number: 1190 • 2019 ACR/ARP Annual Meeting

    A Quality Improvement Project to Increase Documentation Efficiency in an Academic Rheumatology Practice

    David Leverenz1, Jon Golenbiewski 1, Brian Andonian 1, Katherine Kaufman 1, Philip Chu 1, Mithunan Maheswaranathan 1, Andrew Johannemann 1, Jayanth Doss 2 and Lisa Criscione-Schreiber 2, 1Duke University, Durham, NC, 2Duke University, Durham

    Background/Purpose: All providers, including rheumatologists, spend approximately half of their day documenting in an electronic health record (EHR). Excessive documentation is a key contributor to…
  • Abstract Number: 1192 • 2019 ACR/ARP Annual Meeting

    Effect of a Clinical Decision Support System on a Quality Indicator of Glucocorticoid-induced Osteoporosis and Trends of Drug Treatment in a Japanese Hospital

    Hiroki Ozawa1, Sho Fukui 1, Genki Kidoguchi 1, Takehiro Nakai 2, Satoshi Kawaai 1, Ayako Koido 1, Yukihiko Ikeda 1, Masei Suda 1, Haruyuki Yanaoka 1, Hisanori Shimizu 1, Hiromichi Tamaki 1, Tokutaro Tsuda 1, Mitsumasa Kishimoto 3, Kenichi Yamaguchi 1 and Masato Okada 1, 1St.Luke International Hospital Immuno-Rheumatology Center, Tokyo, Japan, 2St.Luke International Hospital Immuno-Rheumatology Center, Tokyo, Tokyo, Japan, 3Immuno-Rheumatology Center, St. Luke’s International Hospital, Tokyo, Japan

    Background/Purpose: Glucocorticoid-induced osteoporosis (GIOP) is a common, preventable and treatable complication of glucocorticoid therapy. We defined quality indicator (QI) for GIOP and took a hospital-wide…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology